Showing results (191-200 of 250) with videos related to

Sort By:
Pageof 25
Cancer|June 15, 1994
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experienceJ Vieweg, W F Whitmore, H W Herr, et al.
The American Journal of Medicine|July 1, 1983
Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experienceG J Bosl, N L Geller, C Cirrincione, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1985
Specificity analysis of mouse monoclonal antibodies defining cell surface antigens of human renal cancerC L Finstad, C Cordon-Cardo, N H Bander, et al.
Cancer|March 15, 1985
Endoscopic diagnosis and treatment of upper-tract urothelial tumors. A preliminary reportJ L Huffman, D H Bagley, E S Lyon, et al.
Urology|April 1, 1981
Automated flow cytometry to monitor intravesical BCG therapy of superficial bladder cancerF A Klein, H W Herr, W F Whitmore, et al.
Cancer|May 1, 1980
Bladder cancer diagnosis by flow cytometry. Correlation between cell samples from biopsy and bladder irrigation fluidL G Collste, M Devonec, Z Darzynkiewicz, et al.
Urology|July 1, 1981
Bladder cancer in men and women treated by radiation therapy and/or radical cystectomyM A Batata, F C Chu, B S Hilaris, et al.
The Journal of Urology|February 1, 1986
Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladderH W Herr, C M Pinsky, W F Whitmore, et al.
American Journal of Clinical Oncology|August 1, 1984
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumorsG J Bosl, A Yagoda, W F Whitmore, et al.
The Journal of Urology|January 1, 1989
Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progressionH W Herr, R A Badalament, D A Amato, et al.
Pageof 25